Uniqure NV share price logo

Uniqure NV

NASDAQ: QURE

Small Cap

$29.10

+1.46

(+5.28%)

as on

Uniqure NV Stock Performance

as on May 13, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $27.05
    $29.83
    downward going graph

    7.04%

    Downside

    2.51%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.73
    $71.50
    downward going graph

    70.00%

    Downside

    145.70%

    Upside

    downward going graph

Uniqure NV share price movements today

Previous Close
$27.64
Open
$27.57
Volume
4.6M
Day's Low - High
$27.05 - $29.83
52 Week Low - High
$8.73 - $71.50

Uniqure NV Historical Returns

1 Month Return
+ 62.39 %
3 Month Return
+ 41.95 %
1 Year Return
+ 127.17 %
3 Year Return
+ 33 %
5 Year Return
-8.2 %

Uniqure NV Stock Fundamentals & Key Indicators

Check Uniqure NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-2.9847

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.18%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-164.3M

Revenue (TTM)

16.1M

Profit Margin

0.00%

Return On Equity TTM

-207.10%

Uniqure NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Uniqure NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Uniqure NV image
Uniqure NV
BUY$1.7B-8.2%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Uniqure NV Stock including INR - Dollar returns

The Uniqure NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Uniqure NV investment value today

Current value as on today

₹2,54,953

Returns

₹1,54,953

(+154.95%)

Returns from Uniqure NV Stock

₹1,27,166 (+127.17%)

Dollar Impact

₹27,786 (+27.79%)

Analyst Recommendation on Uniqure NV Stock

Based on 20 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 20 analysts, 75% of analysts recommend a 'BUY' rating for Uniqure NV. Average target price of $39.6

Uniqure NV Share Price Target

Get share price movements and forecasts by analysts on Uniqure NV.

What analysts predicted

26.52%UPSIDE

Target Price

$39.6

Current Price

$29.1

Analyzed by

20 Analysts

Target

$39.60

Uniqure NV target price $39.6, a slight upside of 26.52% compared to current price of $29.1. According to 20 analysts rating.

Indian Investors' Interest in Uniqure NV Stock

Search interest for Uniqure NV Stock has increased by 137% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:137% versus previous 30 day period

Uniqure NV Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
6
8
11
2
5
1
5
3
5
3
Gross Profit
-2
0
3
1
4
1
4
3
2
3
Operating Income
-61
-54
-44
-40
-45
-39
-43
-51
-52
-44
EBITDA
-50
-46
-36
-24
-53
-23
-18
-51
-49
-36
Interest Expense
15
16
16
16
14
15
15
16
14
14
Depreciation
4
2
2
2
4
4
3
3
2
2
Income Before Tax
-70
-64
-55
-44
-72
-43
-37
-71
-41
-53
Income Tax Expense
3
0
0
0
0
0
0
8
-3
0
Net Income
-73
-65
-56
-44
-73
-43
-37
-80
-37
-53
Net Profit Margin
-1094.42%
-773.34%
-506.01%
-1940.45%
-1403.20%
-2784.75%
-716.82%
-2175.87%
-666.06%
-1502.95%

Uniqure NV Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
25
13
11
7
37
524
106
15
27
16
Gross Profit
25
-54
-61
7
-84
499
103
2
8
14
Operating Income
-71
-71
-88
-121
-125
310
-143
-282
-184
-187
EBITDA
-65
-69
-74
-113
-126
319
-108
-253
-160
-116
Interest Expense
2
2
2
3
3
7
11
41
63
61
Depreciation
-
7
12
6
10
7
8
10
12
14
Income Before Tax
-72
-80
-83
-124
-141
332
-128
-306
-237
-193
Income Tax Expense
1
0
0
3
-16
3
-1
1
2
5
Net Income
-73
-80
-83
-124
-125
329
-126
-308
-239
-198
Net Profit Margin
-292.35%
-613.33%
-738.25%
-1705.82%
-333.27%
62.90%
-119.07%
-1947.09%
-883.35%
-1236.00%

Uniqure NV Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-65
-56
-44
-73
-43
-37
-80
-37
-53
Operating Cash Flow
-60
-32
-36
-52
-44
-39
-16
-77
-38
Investing Cash Flow
63
77
47
-26
20
73
26
-456
98
Financing Cash Flow
-
0
-53
-6
80
0
332
-3
0
Change in Cash
1
44
-37
-92
58
36
343
-516
59

Uniqure NV Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-80
-83
-124
-125
329
-126
-308
-239
-198
Operating Cash Flow
-64
-76
-98
-134
287
-145
-145
-182
-177
Investing Cash Flow
-6
-4
-6
-9
-67
-182
-205
162
-321
Financing Cash Flow
90
157
248
7
94
1
362
-59
415
Change in Cash
26
75
143
-133
311
-328
13
-84
-78

Global Institutional Holdings in Uniqure NV

Funds
Holdings
Jefferies Financial Group Inc
3.82%
Aberdeen Group PLC
8.42%
Fiera Capital Corporation
1.23%
RTW INVESTMENTS, LLC
5.89%
JPMorgan Chase & Co
4.66%
See all

Uniqure NV News & Key Events

    Insights on Uniqure NV

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, QURE stock has moved up by 27.5%

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, QURE has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, QURE has outperformed top 5 stocks with highest market-cap in its industry

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, -37.08M → -53.53M (in $), with an average decrease of 44.4% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 5.56M → 3.56M (in $), with an average decrease of 36.0% per quarter

    About Uniqure NV

    uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
    OrganisationUniqure NV
    HeadquartersPaasheuvelweg 25, Amsterdam, Netherlands, 1105 BP
    IndustryBiotechnology
    CEOMr. Christian Klemt
    E-voting on sharesClick here to vote

    Key Management of Uniqure NV

    Name

    Title

    Dr. Amin Abujoub Ph.D.

    Chief Technical Operations Officer

    Ms. Chiara Elizabeth Russo

    Senior Director of Investor Relations

    Ms. Erin Boyer

    Chief People & Culture Officer

    Prof. Hugo Katus

    Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany

    Mr. Richard Porter Ph.D.

    Chief Business & Scientific Officer

    Dr. Tamara Tugal Ph.D., MBA

    Business Development Director

    Ms. Kylie O'Keefe

    Chief Customer & Strategy Officer

    Mr. Christian Klemt

    CFO, Principal Financial Officer & GM of Amsterdam Site

    Dr. Jeannette Potts J.D., Ph.D.

    Chief Legal & Compliance Officer and Corporate Secretary

    Dr. Walid Abi-Saab M.D.

    Chief Medical Officer

    FAQs

    What is Uniqure NV share price today?

    Uniqure NV share price today is $29.1 as on at the close of the market. Uniqure NV share today touched a day high of $29.83 and a low of $27.05.

    What is the 52 week high and 52 week low for Uniqure NV share?

    Uniqure NV share touched a 52 week high of $71.5 on and a 52 week low of $8.73 on . Uniqure NV stock price today i.e. is closed at $29.1,which is 59.30% down from its 52 week high and 233.33% up from its 52 week low.

    What is Uniqure NV's market capitalisation today?

    Uniqure NV market capitalisation is $0.00T as on .

    How to invest in Uniqure NV Stock (QURE) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Uniqure NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Uniqure NV Shares that will get you 0.0515 shares as per Uniqure NV share price of $29.1 per share as on May 13, 2026 at 8:46 am IST.

    What is the minimum amount required to buy Uniqure NV Stock (QURE) from India?

    Indian investors can start investing in Uniqure NV (QURE) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹957.05 in Uniqure NV stock (as per the Rupee-Dollar exchange rate as on ). Based on Uniqure NV share’s latest price of $29.1 as on May 13, 2026 at 8:46 am IST, you will get 0.3436 shares of Uniqure NV. Learn more about fractional shares .

    What are the returns that Uniqure NV has given to Indian investors in the last 5 years?

    Uniqure NV stock has given -8.2% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?